After reading these articles, you should be able to:
Describe some of the pharmacologic approaches to treatment-resistant depression.
Evaluate the effectiveness of the newer drugs vilazodone (Viibryd), levomilnacipran (Fetzima), vortioxetine (Brintellix), and ketamine in treating depression.
Determine the effectiveness of using light therapy to treat non-seasonal depression.
KarXT (Cobenfy) is the first antipsychotic that doesn’t block dopamine. We trace the origins of this new drug to a South Asian herb used for over 5,000 years, up to the three...
